Dataset Information


Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma.

ABSTRACT: Comparison of microRNA (miRNA) expression profiles in the noncancerous liver tissues adjacent to hepatocelluar carcinomas (HCCs) was a strategy to identify postoperative prognostic predictors in this study. Expression profiles of 270 miRNAs were determined in the paraneoplastic liver tissues of 12 HCC patients with known postoperative prognosis. A panel of candidate miRNA predictors was identified. The prognostic predictive value of these candidate miRNAs was then verified in 216 postoperative HCC patients. Univariate analysis identified 8 and 3 miRNA predictors for recurrence-free (RFS) and overall (OS) survivals, respectively. Multivariate analysis revealed high expression levels of miR-155 (HR, 2.002 [1.324-3.027]; P?=?.001), miR-15a (HR, 0.478 [0.248-0.920]; P?=?.027), miR-432 (HR, 1.816 [1.203-2.740]; P?=?.015), miR-486-3p (HR, 0.543 [0.330-0.893]; P?=?.016), miR-15b (HR, 1.074 [1.002-1.152]; P?=?.043) and miR-30b (HR, 1.102 [1.025-1.185]; P?=?.009) were significantly associated with RFS. When clinicopathological predictors were included, multivariate analysis revealed that tumor number and miR-432, miR-486-3p, and miR-30b expression levels remained significant as independent predictors for RFS. Additionally, expression knockdown of miR-155 in J7 and Mahlavu hepatoma cells resulted in decreased cell growth and enhanced cell death in xenograft tumors, suggesting an oncogenic effect of miR-155. In conclusion, significant prognostic miRNA predictors were identified through examination of miRNA expression levels in paraneoplastic liver tissues. Functional analysis of a miRNA predictor, miR-155, suggested that the prognostic miRNA predictors identified under this strategy could serve as potential molecular targets for anticancer therapy.


PROVIDER: S-EPMC3358336 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5675676 | BioStudies
2020-01-01 | S-EPMC7288910 | BioStudies
1000-01-01 | S-EPMC3551827 | BioStudies
1000-01-01 | S-EPMC5739810 | BioStudies
2019-01-01 | S-EPMC6336320 | BioStudies
2017-01-01 | S-EPMC5627931 | BioStudies
2018-01-01 | S-EPMC6140736 | BioStudies
2014-01-01 | S-EPMC4097394 | BioStudies
2019-01-01 | S-EPMC6469283 | BioStudies
2015-01-01 | S-EPMC4556438 | BioStudies